UBS Group »

Veradermics shares owned by UBS Group

Quarter-by-quarter ownership of Veradermics (MANE) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Veradermics

Tip: Access up to 7 years of quarterly data

All positions including Veradermics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Veradermics by UBS Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $83M 671k 122.94
2026-03-31 $22M 347k 63.15

More positions owned by UBS Group

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Micron Technology (MU)
Eli Lilly & Co. (LLY)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for UBS Group

Top funds holding Veradermics

Suvretta Capital Management
FMR
Sr One Capital Management
Deep Track Capital
Citadel Advisors
Siren
BlackRock
Viking Global Investors
Jpmorgan Chase & Co
Standard Life Aberdeen
D. E. Shaw & Co
Vanguard Capital Management
Maverick Capital
Jennison Associates
Infinitum Asset Management

View all funds holding Veradermics